Will The Rally In Cassava Sciences Stock Continue After A Large 66% Rise In A Month?
- Tuesday, June 22, 2021, 7:12
- Market
- Add a comment
The stock price of Cassava Sciences, a clinical stage biotechnology company focused on treatment for Alzheimer’s disease, has seen a massive 66% rise over the last twenty-one trading days, while it is up a whopping 10x year-to-date, rising from levels of around $7 at the beginning of the year to…
About the Author
admin123 has written 23418 stories on this site.
